MarketPulse

Clare Fisher

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Molecular Partners Wins Shareholder Approval, Adds Pharma Veteran Clare Fisher to Board

Molecular Partners shareholders approved all board proposals and elected pharma veteran Clare Fisher as director. The company reported CHF 57.9M loss in 2025 with CHF 257.3M accumulated deficit.
MOLNfinancial resultsclinical-stage biotech
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Molecular Partners Taps Healthcare M&A Veteran Clare Fisher for Board Seat

Molecular Partners nominates M&A veteran Clare Fisher to its board as 12-year member Steven Holtzman retires, signaling strategic emphasis on business development and partnerships.
MOLNONCbiotechAnnual General Meeting